Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-25-005327
Filing Date
2025-12-17
Accepted
2025-12-17 08:06:05
Documents
6

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10544
2 SCHEDULE A p25-2605schedulea.htm EX-99.A 4667
3 DECEMBER 17 LETTER p25-2605exh99_2.htm EX-99.2 35228
4 GRAPHIC image_001.jpg GRAPHIC 1848
5 GRAPHIC image_003.jpg GRAPHIC 4048
6 GRAPHIC image_002.jpg GRAPHIC 163646
  Complete submission text file 0000902664-25-005327.txt   286045
Mailing Address 220 E FIRST ST BETHLEHEM PA 18015
Business Address 220 E FIRST ST BETHLEHEM PA 18015 5036416115
ORASURE TECHNOLOGIES INC (Subject) CIK: 0001116463 (see all company filings)

EIN.: 364370966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-59673 | Film No.: 251577294
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address PO BOX 15203 IRVINE CA 92623-9998
Business Address 9040 SUNSET BLVD #1004 WEST HOLLYWOOD CA 90069 949-326-9611
Altai Capital Management, L.P. (Filed by) CIK: 0001478982 (see all company filings)

EIN.: 270488863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A